行业动态 - 郑州微飒生物科技有限责任公司

药效评价Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.

期刊：British journal of pharmacology发表年份：2007作者：B Bingham; P G Jones; A J Uveges; S Kotnis; P Lu; V A Smith; S-C Sun; L Resnick; M Chlenov; Y He; B W Strassle; T A Cummons; M J Piesla; J E Harrison; G T Whiteside; J D Kennedy

阅读更多 →

药效评价Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2007作者：Takuma Mihara; Kayoko Mihara; Junko Yarimizu; Yasuyuki Mitani; Ritsuko Matsuda; Hiroko Yamamoto; Satoshi Aoki; Atsushi Akahane; Akinori Iwashita; Nobuya Matsuoka

阅读更多 →

药效评价F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile.

期刊：British journal of pharmacology发表年份：2007作者：A Newman-Tancredi; M-B Assié; J-C Martel; C Cosi; L Bruins Slot; C Palmier; I Rauly-Lestienne; F Colpaert; B Vacher; D Cussac

阅读更多 →

药效评价Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2007作者：Narender R Gavva; Anthony W Bannon; David N Hovland; Sonya G Lehto; Lana Klionsky; Sekhar Surapaneni; David C Immke; Charles Henley; Leyla Arik; Annette Bak; James Davis; Nadia Ernst; Gal Hever; Rongzhen Kuang; Licheng Shi; Rami Tamir; Jue Wang; Weiy

阅读更多 →